First human trial of Bundibugyo Ebola vaccine begins
First publishedJul 14, 02:08 UTC
Last updatedJul 14, 02:51 UTC · just now ago
1 outlet
Seattle Times
1 outlets over time — hover a bar for its window & outletslast updated
Answer
The world's first clinical trial of a vaccine targeting the Bundibugyo strain of Ebola has begun, marking a milestone in efforts to contain the outbreak in central Africa.
Reported by 1 outlet — Seattle Times. See all sources ↓
Read the full report at Seattle Times ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- The world's first clinical trial of a vaccine targeting the Bundibugyo strain of Ebola has begun, marking a milestone in efforts to contain the outbreak in central Africa.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- just now ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
First human trial of Bundibugyo Ebola vaccine begins
Sources1TypeCoverage
Related in the knowledge graph
organizationAfricaorganizationBundibugyoorganizationBundibugyo EbolaorganizationEbolaorganizationFirst
Sources (1)
Avg source rating 6.0/10